FTC Sues PBMs Over Insulin Prices, Citing a ‘Perverse System’
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said Friday in announcing an administrative complaint against firms that are divisions of CVS Health,
FTC Takes Legal Action Against Three Largest PBMs Over High Insulin Prices
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed,
FTC sues big 3 PBMs for ‘artificially inflated’ insulin prices caused by ‘perverse’ rebating
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to pay more for insulin.
FTC targets 3 biggest PBMs over insulin rebates
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
FTC sues nation's 3 largest PBMs: 10 notes
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
FTC Sues PBMs for Artificially Hiking Insulin Prices
The complaint targets the group purchasing organizations affiliated with the "big three" pharmacy benefit managers: CVS Caremark, Optum Rx and Express Scripts.
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
Feds sue pharmacy gatekeepers over high insulin costs
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming they are illegally maximizing profits by steering patients to high-cost insulin products.
FTC Sues CVS Health, Cigna And United Health Group For Inflating Insulin Prices
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
Fierce Healthcare1d
FTC formally sues PBMs over insulin prices and warns manufacturers
“As the complaint explains, the PBMs have created and manage a system in which drug manufacturers compete for formulary ...
The American Journal of Managed Care1d
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
Axios Vitals on MSN4d
Oregon lawmakers may target PBMs to regulate pharmacist pay
Some Oregon lawmakers say they plan to propose regulations on pharmacy benefit managers, following the lead of Congress and ...
Las Cruces Sun-News on MSN6d
Reining in PBMs to lower prescription drug costs for New Mexicans
After years of work and various proposals, there's finally a groundswell to take on the actor most responsible for ...
High Insulin Prices Spur a Federal Lawsuit Against Three Pharmacy Benefit Managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...